4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001415889-24-005780
Director sold 807,838 shares at an average $24.30 ($19,626,903)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rhodes Jason P Director | 2024-02-26 | Sale 10b5-1 | −136,312 | $23.59 | $3,215,600 | 6,216,250 | I |
| Rhodes Jason P Director | 2024-02-26 | Sale 10b5-1 | −64,783 | $23.98 | $1,553,496 | 6,151,467 | I |
| Rhodes Jason P Director | 2024-02-26 | Sale 10b5-1 | −20,205 | $23.59 | $476,636 | 1,564,932 | I |
| Rhodes Jason P Director | 2024-02-26 | Sale 10b5-1 | −9,603 | $23.98 | $230,280 | 1,555,329 | I |
| Rhodes Jason P Director | 2024-02-26 | Sale 10b5-1 | −11,736 | $23.59 | $276,852 | 909,107 | I |
| Rhodes Jason P Director | 2024-02-26 | Sale 10b5-1 | −5,580 | $23.98 | $133,808 | 903,527 | I |
| Rhodes Jason P Director | 2024-02-27 | Sale 10b5-1 | −272,923 | $24.38 | $6,653,863 | 5,878,544 | I |
| Rhodes Jason P Director | 2024-02-27 | Sale 10b5-1 | −25,779 | $24.68 | $636,226 | 5,852,765 | I |
| Rhodes Jason P Director | 2024-02-27 | Sale 10b5-1 | −40,455 | $24.38 | $986,293 | 1,514,874 | I |
| Rhodes Jason P Director | 2024-02-27 | Sale 10b5-1 | −3,821 | $24.68 | $94,302 | 1,511,053 | I |
| Rhodes Jason P Director | 2024-02-27 | Sale 10b5-1 | −23,505 | $24.38 | $573,052 | 880,022 | I |
| Rhodes Jason P Director | 2024-02-27 | Sale 10b5-1 | −2,216 | $24.68 | $54,691 | 877,806 | I |
| Rhodes Jason P Director | 2024-02-28 | Sale 10b5-1 | −152,244 | $24.83 | $3,780,219 | 5,700,521 | I |
| Rhodes Jason P Director | 2024-02-28 | Sale 10b5-1 | −2,430 | $25.25 | $61,358 | 5,698,091 | I |
| Rhodes Jason P Director | 2024-02-28 | Sale 10b5-1 | −22,567 | $24.83 | $560,339 | 1,488,486 | I |
| Rhodes Jason P Director | 2024-02-28 | Sale 10b5-1 | −360 | $25.25 | $9,090 | 1,488,126 | I |
| Rhodes Jason P Director | 2024-02-28 | Sale 10b5-1 | −13,109 | $24.83 | $325,496 | 864,697 | I |
| Rhodes Jason P Director | 2024-02-28 | Sale 10b5-1 | −210 | $25.25 | $5,303 | 864,487 | I |
| Open-market sales · 807,838 sh · avg $24.30 · $19,626,903 | |||||||
Loading xslF345X05/form4-02292024_120235.xml…